These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34816326)

  • 1. Nonalcoholic Fatty Liver Disease Underdiagnosis in Primary Care: What Are We Missing?
    Nielsen EM; Anderson KP; Marsden J; Zhang J; Schreiner AD
    J Gen Intern Med; 2022 Aug; 37(10):2587-2590. PubMed ID: 34816326
    [No Abstract]   [Full Text] [Related]  

  • 2. [The fatty liver epidemic: An analysis from the primary care].
    Caballeria L; Torán P
    Aten Primaria; 2019 Nov; 51(9):525-526. PubMed ID: 31718777
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonalcoholic Fatty Liver Disease.
    Sweet PH; Khoo T; Nguyen S
    Prim Care; 2017 Dec; 44(4):599-607. PubMed ID: 29132522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of comorbidities in nonalcoholic fatty liver disease.
    Song SJ; Wong VW
    Clin Mol Hepatol; 2023 Apr; 29(2):384-389. PubMed ID: 36916170
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic Challenges.
    Cholankeril G; Perumpail RB; Pham EA; Ahmed A; Harrison SA
    Hepatology; 2016 Sep; 64(3):954. PubMed ID: 27388553
    [No Abstract]   [Full Text] [Related]  

  • 6. An update on nonalcoholic fatty liver disease.
    Provencher DM
    JAAPA; 2014 Jul; 27(7):18-22. PubMed ID: 24901731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.
    Della Corte C; Mosca A; Majo F; Lucidi V; Panera N; Giglioni E; Monti L; Stronati L; Alisi A; Nobili V
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):656-62. PubMed ID: 26201937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Invasive Diagnosis of Nonalcoholic Fatty Liver Disease.
    Yoneda M; Imajo K; Nakajima A
    Am J Gastroenterol; 2018 May; 113(10):1409-1411. PubMed ID: 29937542
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External Validation of the Nonalcoholic Steatohepatitis Scoring System in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease in China.
    Xu K; Zheng KI; Zheng MH
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):412-413. PubMed ID: 33248101
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Spengler EK; Loomba R
    Mayo Clin Proc; 2015 Sep; 90(9):1233-46. PubMed ID: 26219858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of insomnia with gastroesophageal reflux symptoms in biopsy-proven nonalcoholic fatty liver disease.
    Taketani H; Sumida Y; Tanaka S; Imajo K; Yoneda M; Hyogo H; Ono M; Fujii H; Eguchi Y; Kanemasa K; Chayama K; Itoh Y; Yoshikawa T; Saibara T; Fujimoto K; Nakajima A;
    J Gastroenterol; 2014 Jul; 49(7):1163-74. PubMed ID: 23975270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Kanneganti M; Singal AG
    Gastroenterology; 2022 May; 162(6):1772-1774. PubMed ID: 35120916
    [No Abstract]   [Full Text] [Related]  

  • 14. Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease.
    Prasoppokakorn T; Chan WK; Wong VW; Pitisuttithum P; Mahadeva S; Nik Mustapha NR; Wong GL; Leung HH; Sripongpun P; Treeprasertsuk S
    World J Gastroenterol; 2022 Apr; 28(15):1563-1573. PubMed ID: 35582126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between nonalcoholic fatty liver disease and portal vein thrombosis: a systematic review and meta-analysis.
    Lin H; Bai Z; Guo X; Qi X
    Eur J Gastroenterol Hepatol; 2020 Oct; 32(10):1405-1406. PubMed ID: 32858662
    [No Abstract]   [Full Text] [Related]  

  • 16. Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population: a cross-sectional study.
    Kim HJ; Kim JH; Choe WH; Kwon SY; Lee CH
    Clin Mol Hepatol; 2014 Jun; 20(2):154-61. PubMed ID: 25032181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Steatohepatitis: Histopathology Basics Within a Broader Context.
    Schild MH; Guy CD
    Surg Pathol Clin; 2018 Jun; 11(2):267-285. PubMed ID: 29751874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom.
    Gunn NT; Shiffman ML
    Clin Liver Dis; 2018 Feb; 22(1):109-119. PubMed ID: 29128050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease.
    Duseja A; Singh SP; Mehta M; Shalimar ; Venkataraman J; Mehta V; Devadas K; Kar SK; Goyal O; Nagral A; Saigal S; Nijhawan S; Praharaj D; Shukla A; Sharma B; Narayanasamy K; Kumar P; Rao PN; Arora A; Mehta R; Asati P; Ranjan P; Koshy A; Alam S; Mukewar S; Mukewar S; Mohan Prasad VG; Rastogi M; Sanyal AJ
    Metab Syndr Relat Disord; 2022 Apr; 20(3):166-173. PubMed ID: 35085026
    [No Abstract]   [Full Text] [Related]  

  • 20. A Meta-Analysis of Sleep Disorders and Nonalcoholic Fatty Liver Disease: Potential Causality and Symptom Management.
    Yu L; Lin C; Chen X; Teng Y; Zhou S; Liang Y
    Gastroenterol Nurs; 2022 Sep-Oct 01; 45(5):354-363. PubMed ID: 35913418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.